National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 2) (PB 12 of 2015)

Link to law: https://www.comlaw.gov.au/Details/F2015L00207

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 12 of 2015
 
National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 2)
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 23rd February 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 2).
(2)                This Instrument may also be cited as PB 12 of 2015.
2              Commencement                                                        
                This instrument commences on 1 March 2015.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]           Schedule 4, after entry for Clonazepam
insert:
Coal tar
Foam 20 mg per g, 100 g
[2]           Schedule 4, entry for Escitalopram
omit:
 
Oral solution 10 mg (as oxalate) per mL, 28 mL
[3]           Schedule 4, after entry for entry for Glucose Indicator—Blood in the form
Test strips, 100 (Contour next)
insert in the column headed “Form (strength, type, size, etc.)”:
 
Test strips, 100 (Dario)
[4]           Schedule 4, after entry for Macrogol 3350 in the form Sachets containing powder for oral solution 17 g, 30
insert:
Mercaptopurine
Oral suspension 20 mg per mL, 100 mL
[5]           Schedule 4, after entry for Paraffin
insert:
Peginterferon beta-1a
Pack containing single use injection pens containing 63 micrograms in
0.5 mL and 94 micrograms in 0.5 mL